236 related articles for article (PubMed ID: 33347879)
1. Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease.
Jamialahmadi O; Mancina RM; Ciociola E; Tavaglione F; Luukkonen PK; Baselli G; Malvestiti F; Thuillier D; Raverdy V; Männistö V; Pipitone RM; Pennisi G; Prati D; Spagnuolo R; Petta S; Pihlajamäki J; Pattou F; Yki-Järvinen H; Valenti L; Romeo S
Gastroenterology; 2021 Apr; 160(5):1634-1646.e7. PubMed ID: 33347879
[TBL] [Abstract][Full Text] [Related]
2. Allele-specific variation at APOE increases nonalcoholic fatty liver disease and obesity but decreases risk of Alzheimer's disease and myocardial infarction.
Palmer ND; Kahali B; Kuppa A; Chen Y; Du X; Feitosa MF; Bielak LF; O'Connell JR; Musani SK; Guo X; Smith AV; Ryan KA; Eirksdottir G; Allison MA; Bowden DW; Budoff MJ; Carr JJ; Chen YI; Taylor KD; Correa A; Crudup BF; Halligan B; Yang J; Kardia SLR; Launer LJ; Fu YP; Mosley TH; Norris JM; Terry JG; O'Donnell CJ; Rotter JI; Wagenknecht LE; Gudnason V; Province MA; Peyser PA; Speliotes EK
Hum Mol Genet; 2021 Jul; 30(15):1443-1456. PubMed ID: 33856023
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic opportunities for the treatment of NASH with genetically validated targets.
Lindén D; Romeo S
J Hepatol; 2023 Oct; 79(4):1056-1064. PubMed ID: 37207913
[TBL] [Abstract][Full Text] [Related]
4. A minority of somatically mutated genes in pre-existing fatty liver disease have prognostic importance in the development of NAFLD.
Mann JP; Hoare M
Liver Int; 2022 Aug; 42(8):1823-1835. PubMed ID: 35474605
[TBL] [Abstract][Full Text] [Related]
5. Genetic Variation in the Mitochondrial Glycerol-3-Phosphate Acyltransferase Is Associated With Liver Injury.
Hakim A; Moll M; Brancale J; Liu J; Lasky-Su JA; Silverman EK; Vilarinho S; Jiang ZG; Pita-Juárez YH; Vlachos IS; Zhang X; Åberg F; Afdhal NH; Hobbs BD; Cho MH
Hepatology; 2021 Dec; 74(6):3394-3408. PubMed ID: 34216018
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease.
Chen Y; Du X; Kuppa A; Feitosa MF; Bielak LF; O'Connell JR; Musani SK; Guo X; Kahali B; Chen VL; Smith AV; Ryan KA; Eirksdottir G; Allison MA; Bowden DW; Budoff MJ; Carr JJ; Chen YI; Taylor KD; Oliveri A; Correa A; Crudup BF; Kardia SLR; Mosley TH; Norris JM; Terry JG; Rotter JI; Wagenknecht LE; Halligan BD; Young KA; Hokanson JE; Washko GR; Gudnason V; Province MA; Peyser PA; Palmer ND; Speliotes EK
Nat Genet; 2023 Oct; 55(10):1640-1650. PubMed ID: 37709864
[TBL] [Abstract][Full Text] [Related]
7. Genome-Wide Association Study of NAFLD Using Electronic Health Records.
Fairfield CJ; Drake TM; Pius R; Bretherick AD; Campbell A; Clark DW; Fallowfield JA; Hayward C; Henderson NC; Joshi PK; Mills NL; Porteous DJ; Ramachandran P; Semple RK; Shaw CA; Sudlow CLM; Timmers PRHJ; Wilson JF; Wigmore SJ; Harrison EM; Spiliopoulou A
Hepatol Commun; 2022 Feb; 6(2):297-308. PubMed ID: 34535985
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic fatty liver disease is a risk factor for glucose intolerance onset in men regardless of alanine aminotransferase status.
Miyake T; Matsuura B; Furukawa S; Yoshida O; Hirooka M; Kumagi T; Ishihara T; Kanzaki S; Nakaguchi H; Miyazaki M; Nakamura Y; Yamamoto Y; Koizumi Y; Tokumoto Y; Takeshita E; Ikeda Y; Abe M; Kitai K; Hiasa Y
J Diabetes Investig; 2021 Oct; 12(10):1890-1898. PubMed ID: 33742744
[TBL] [Abstract][Full Text] [Related]
9. Toward Genetic Prediction of Nonalcoholic Fatty Liver Disease Trajectories: PNPLA3 and Beyond.
Krawczyk M; Liebe R; Lammert F
Gastroenterology; 2020 May; 158(7):1865-1880.e1. PubMed ID: 32068025
[TBL] [Abstract][Full Text] [Related]
10. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease.
Kozlitina J; Smagris E; Stender S; Nordestgaard BG; Zhou HH; Tybjærg-Hansen A; Vogt TF; Hobbs HH; Cohen JC
Nat Genet; 2014 Apr; 46(4):352-6. PubMed ID: 24531328
[TBL] [Abstract][Full Text] [Related]
11. Impact of genetic polymorphisms associated with nonalcoholic fatty liver disease on HIV-infected individuals.
Macias J; Rivero-Juarez A; Neukam K; Tellez F; Merino D; Frias M; Merchante N; Rivero A; Pineda JA; Real LM;
AIDS; 2015 Sep; 29(15):1927-35. PubMed ID: 26352879
[TBL] [Abstract][Full Text] [Related]
12. Genetic predisposition in metabolic-dysfunction-associated fatty liver disease and cardiovascular outcomes-Systematic review.
Ismaiel A; Dumitrascu DL
Eur J Clin Invest; 2020 Oct; 50(10):e13331. PubMed ID: 32589269
[TBL] [Abstract][Full Text] [Related]
13. Genetic Architecture of the Cardiovascular Risk Proteome.
Benson MD; Yang Q; Ngo D; Zhu Y; Shen D; Farrell LA; Sinha S; Keyes MJ; Vasan RS; Larson MG; Smith JG; Wang TJ; Gerszten RE
Circulation; 2018 Mar; 137(11):1158-1172. PubMed ID: 29258991
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants in COL13A1, ADIPOQ and SAMM50, in addition to the PNPLA3 gene, confer susceptibility to elevated transaminase levels in an admixed Mexican population.
Larrieta-Carrasco E; Flores YN; Macías-Kauffer LR; Ramírez-Palacios P; Quiterio M; Ramírez-Salazar EG; León-Mimila P; Rivera-Paredez B; Cabrera-Álvarez G; Canizales-Quinteros S; Zhang ZF; López-Pérez TV; Salmerón J; Velázquez-Cruz R
Exp Mol Pathol; 2018 Feb; 104(1):50-58. PubMed ID: 29307798
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation and elevated liver enzymes during childhood, adolescence and early adulthood.
Stender S; Davey Smith G; Richardson TG
Int J Epidemiol; 2023 Oct; 52(5):1341-1349. PubMed ID: 37105232
[TBL] [Abstract][Full Text] [Related]
16. The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage.
Donati B; Motta BM; Pingitore P; Meroni M; Pietrelli A; Alisi A; Petta S; Xing C; Dongiovanni P; del Menico B; Rametta R; Mancina RM; Badiali S; Fracanzani AL; Craxì A; Fargion S; Nobili V; Romeo S; Valenti L
Hepatology; 2016 Mar; 63(3):787-98. PubMed ID: 26605757
[TBL] [Abstract][Full Text] [Related]
17. The Effects of Extra Virgin Olive Oil on Alanine Aminotransferase, Aspartate Aminotransferase, and Ultrasonographic Indices of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients Undergoing Low Calorie Diet.
Shidfar F; Bahrololumi SS; Doaei S; Mohammadzadeh A; Gholamalizadeh M; Mohammadimanesh A
Can J Gastroenterol Hepatol; 2018; 2018():1053710. PubMed ID: 29850450
[TBL] [Abstract][Full Text] [Related]
18. Association of Genetic Variation With Cirrhosis: A Multi-Trait Genome-Wide Association and Gene-Environment Interaction Study.
Emdin CA; Haas M; Ajmera V; Simon TG; Homburger J; Neben C; Jiang L; Wei WQ; Feng Q; Zhou A; Denny J; Corey K; Loomba R; Kathiresan S; Khera AV
Gastroenterology; 2021 Apr; 160(5):1620-1633.e13. PubMed ID: 33310085
[TBL] [Abstract][Full Text] [Related]
19. Inherited non-alcoholic fatty liver disease and dyslipidemia due to monoallelic ABHD5 mutations.
Youssefian L; Vahidnezhad H; Saeidian AH; Pajouhanfar S; Sotoudeh S; Mansouri P; Amirkashani D; Zeinali S; Levine MA; Peris K; Colombo R; Uitto J
J Hepatol; 2019 Aug; 71(2):366-370. PubMed ID: 30954460
[TBL] [Abstract][Full Text] [Related]
20. Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease.
Joo SK; Kim W; Kim D; Kim JH; Oh S; Lee KL; Chang MS; Jung YJ; So YH; Lee MS; Bae JM; Kim BG
Liver Int; 2018 Feb; 38(2):331-341. PubMed ID: 28796410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
